Tuberculosis requires specific chemicals delivered in specific quantities. But there was a way to make money here, too: the healthcare insiders cut the amount of chemical in each dose, by pretending the average patient weighed less than he did, and thus saved on the amount of chemicals they needed to buy. The consequence was that the drugs didn’t work, which drove the growth of the multidrug-resistant TB strains that are now such a threat there.
